产品图片
货号/SKU
NR-45880
货号/规格
EA
库存与交货期
3-8周
人民币价格
14000
试剂海关审批
A/B级风险物质只能直接使用人购买并持有实验室有效资质,其它询客服确认
国外采购
支持/部分限制一年内购买数量
厂牌
BEI Resources(ATCC)
产品基础信息
生物安全等级建议分类:美国、2
产品描述信息
NR-45880??Staphylococcus aureus, LIM 1(Bacteria)|Staphylococcus aureus|LIM 1|-60°C or colder|NARSAAcknowledgment for publications should read "The following reagent was provided by the Network on Antimicrobial Resistance in Staphylococcus aureus (NARSA) for distribution by BEI Resources, NIAID, NIH: Staphylococcus aureus, Strain LIM 1, NR-45880."|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.
Staphylococcus aureus (S. aureus), strain LIM 1 (also referred to as NRS35) was isolated in 1995 from the bloodstream of a 2-year-old female patient with leukemia in France.
S. aureus, strain LIM 1 is a methicillin-resistant S. aureus (MRSA) and a vancomycin-sensitive S. aureus (VSSA) strain. S. aureus, strain LIM 1 was deposited as positive for mec (subtype I); negative for vanA, vanB, vanC1, vanC2, vanD, and vanE; MLST sequencing type (ST) 572; eGenomic spa type 4, eGenomic spa repeats YHFGFMBQBLO; Ridom spa type t051. Strain LIM 1 was the first MRSA isolate recovered from this patient. During the course of treatment, which included the use of glycopeptides, three additional MRSA strains, LIM 2 (NRS36), LIM 3 (NRS37) and LIM 4, were isolated and found to have a vancomycin-intermediate S. aureus (VISA) phenotype. Results from pulsed-field gel electrophoresis suggest that these three VISA strains were selected from LIM 1.
Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth supplemented with 10% glycerol.
Staphylococcus aureus (S. aureus), strain LIM 1 (also referred to as NRS35) was isolated in 1995 from the bloodstream of a 2-year-old female patient with leukemia in France.
S. aureus, strain LIM 1 is a methicillin-resistant S. aureus (MRSA) and a vancomycin-sensitive S. aureus (VSSA) strain. S. aureus, strain LIM 1 was deposited as positive for mec (subtype I); negative for vanA, vanB, vanC1, vanC2, vanD, and vanE; MLST sequencing type (ST) 572; eGenomic spa type 4, eGenomic spa repeats YHFGFMBQBLO; Ridom spa type t051. Strain LIM 1 was the first MRSA isolate recovered from this patient. During the course of treatment, which included the use of glycopeptides, three additional MRSA strains, LIM 2 (NRS36), LIM 3 (NRS37) and LIM 4, were isolated and found to have a vancomycin-intermediate S. aureus (VISA) phenotype. Results from pulsed-field gel electrophoresis suggest that these three VISA strains were selected from LIM 1.
Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth supplemented with 10% glycerol.
主要内容
此项目的每个订单数量限制为1.此商品每年可订购两次.此限制的订单将在发货前发送到NIAID进行批准. 金黄色葡萄球菌(金黄色葡萄球菌),菌株LIM 1(也称为NRS35)是1995年从1995年孤立的一名2岁女性患者的血液与白血病在法国. s. AUREUS ,菌株LIM1是耐甲氧胞蛋白的.金黄色葡萄球菌(MRSA)和万古霉素敏感性 s.金黄色葡萄球菌(VSSA)应变. s.金黄色葡萄球菌,将菌株LIM 1沉积为 MEC (亚型I)阳性; vana, Vanb , Vanc1 , Vanc2 , vand ,和 vane ; MLST测序类型(ST)572; Egenomic Spa 型4,eGenomic Spa 重复Yhfgfmbqlo; ridom spa type t051型.菌株LIM 1是从该患者回收的第一个MRSA分离物.在治疗过程中,包括使用糖肽的使用,分离出三个另外的MRSA菌株,LIM 2(NRS36),LIM 3(NRS37)和LIM 4,发现具有万古霉素中间体℃.金黄色葡萄球菌(VISA)表型.脉冲场凝胶电泳的结果表明,从LIM 1中选择这三种缺陷菌株1. 每个小瓶在补充有10%甘油的胰蛋白酶大豆肉汤中含有大约0.5ml的细菌培养物.
厂牌介绍
BEI Resources 由美国国家过敏和传染病研究所 ( NIAID )成立,旨在为研究 A、B 和 C 类优先病原体、新兴传染病病原体、非病原微生物和其他相关微生物材料提供试剂、工具和信息到研究界。BEI Resources 获取、验证和生产科学家进行基础研究和开发改进的诊断测试、疫苗和疗法所需的试剂。通过将这些功能集中在 BEI Resources 中,可以监控科学界对这些材料的访问和使用,并确保试剂的质量控制。
除了为传染病界提供材料外,BEI Resources 还鼓励和支持研究人员和机构的材料存放。使用 BEI Resources存放材料对研究人员和研究社区有许多优势,包括安全存储、社区访问和分发;同时保护存款人的知识产权。只要有需要,BEI 资源库将作为研究人员的资源进行维护。您在 BEI Resources 的存款是一项有助于未来研究的长期投资。
BEI Resources 自 2003 年起由美国典型培养物保藏中心 (ATCC) 根据合同管理。2016 年 5 月, ATCC获得了一份为期七年的继续管理 BEI Resources的合同。合同范围已扩大到更全面的研究目录材料,包括由其他政府支持的研究项目存放的材料,将提供给生物防御和新兴传染病科学界。真菌、寄生虫、载体和其他相关材料已添加到现有的细菌、病毒和毒素试剂中,涵盖 NIAID A、B 和 C 类优先病原体和 NIAID 指定的新发传染病病原体和生物。
品牌标识
可能感兴趣的内容
2023-12-21
2021-12-13
2022-01-10
2024-11-13
2021-12-21
2021-12-02
2021-12-21
2022-03-22
2021-12-02
2021-10-31
2022-04-01
2023-10-30
2022-04-01
2024-08-16